nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—PTK2B—Alzheimer's disease	0.693	1	CbGaD
Leflunomide—CYP2C9—Donepezil—Alzheimer's disease	0.0305	1	CbGbCtD
Leflunomide—PTK2B—embryo—Alzheimer's disease	0.00179	0.145	CbGeAlD
Leflunomide—PTK2B—forebrain—Alzheimer's disease	0.00159	0.128	CbGeAlD
Leflunomide—PTK2B—telencephalon—Alzheimer's disease	0.00146	0.118	CbGeAlD
Leflunomide—Niflumic Acid—PTGS1—Alzheimer's disease	0.00136	0.636	CrCbGaD
Leflunomide—AHR—telencephalon—Alzheimer's disease	0.0012	0.0969	CbGeAlD
Leflunomide—DHODH—brain—Alzheimer's disease	0.00104	0.084	CbGeAlD
Leflunomide—PTK2B—nervous system—Alzheimer's disease	0.000861	0.0696	CbGeAlD
Leflunomide—PTK2B—central nervous system—Alzheimer's disease	0.000829	0.067	CbGeAlD
Leflunomide—PTK2B—cerebellum—Alzheimer's disease	0.00081	0.0655	CbGeAlD
Leflunomide—Niflumic Acid—PTGS2—Alzheimer's disease	0.00078	0.364	CrCbGaD
Leflunomide—AHR—cerebellum—Alzheimer's disease	0.000666	0.0538	CbGeAlD
Leflunomide—PTK2B—brain—Alzheimer's disease	0.000658	0.0532	CbGeAlD
Leflunomide—AHR—brain—Alzheimer's disease	0.000541	0.0437	CbGeAlD
Leflunomide—ABCG2—telencephalon—Alzheimer's disease	0.000465	0.0376	CbGeAlD
Leflunomide—Infestation—Rivastigmine—Alzheimer's disease	0.000296	0.00158	CcSEcCtD
Leflunomide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000296	0.00157	CcSEcCtD
Leflunomide—Oedema peripheral—Donepezil—Alzheimer's disease	0.000295	0.00157	CcSEcCtD
Leflunomide—Urinary tract infection—Memantine—Alzheimer's disease	0.000294	0.00156	CcSEcCtD
Leflunomide—Conjunctivitis—Memantine—Alzheimer's disease	0.000294	0.00156	CcSEcCtD
Leflunomide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000294	0.00156	CcSEcCtD
Leflunomide—Urethral disorder—Donepezil—Alzheimer's disease	0.000293	0.00156	CcSEcCtD
Leflunomide—Cough—Galantamine—Alzheimer's disease	0.000293	0.00156	CcSEcCtD
Leflunomide—Renal failure—Rivastigmine—Alzheimer's disease	0.000291	0.00155	CcSEcCtD
Leflunomide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00029	0.00154	CcSEcCtD
Leflunomide—Hypertension—Galantamine—Alzheimer's disease	0.00029	0.00154	CcSEcCtD
Leflunomide—Haematuria—Memantine—Alzheimer's disease	0.000289	0.00154	CcSEcCtD
Leflunomide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000288	0.00153	CcSEcCtD
Leflunomide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000288	0.00153	CcSEcCtD
Leflunomide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000286	0.00152	CcSEcCtD
Leflunomide—Arthralgia—Galantamine—Alzheimer's disease	0.000286	0.00152	CcSEcCtD
Leflunomide—Chest pain—Galantamine—Alzheimer's disease	0.000286	0.00152	CcSEcCtD
Leflunomide—Myalgia—Galantamine—Alzheimer's disease	0.000286	0.00152	CcSEcCtD
Leflunomide—Epistaxis—Memantine—Alzheimer's disease	0.000286	0.00152	CcSEcCtD
Leflunomide—Anxiety—Galantamine—Alzheimer's disease	0.000285	0.00152	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000284	0.00151	CcSEcCtD
Leflunomide—Sinusitis—Memantine—Alzheimer's disease	0.000284	0.00151	CcSEcCtD
Leflunomide—Discomfort—Galantamine—Alzheimer's disease	0.000283	0.0015	CcSEcCtD
Leflunomide—Agranulocytosis—Memantine—Alzheimer's disease	0.000283	0.0015	CcSEcCtD
Leflunomide—Haematuria—Rivastigmine—Alzheimer's disease	0.000282	0.0015	CcSEcCtD
Leflunomide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00028	0.00149	CcSEcCtD
Leflunomide—Dry mouth—Galantamine—Alzheimer's disease	0.00028	0.00149	CcSEcCtD
Leflunomide—Epistaxis—Rivastigmine—Alzheimer's disease	0.000279	0.00149	CcSEcCtD
Leflunomide—Sinusitis—Rivastigmine—Alzheimer's disease	0.000278	0.00148	CcSEcCtD
Leflunomide—Haemoglobin—Memantine—Alzheimer's disease	0.000273	0.00145	CcSEcCtD
Leflunomide—Rhinitis—Memantine—Alzheimer's disease	0.000272	0.00145	CcSEcCtD
Leflunomide—Haemorrhage—Memantine—Alzheimer's disease	0.000272	0.00145	CcSEcCtD
Leflunomide—Hepatitis—Memantine—Alzheimer's disease	0.000272	0.00145	CcSEcCtD
Leflunomide—Pharyngitis—Memantine—Alzheimer's disease	0.00027	0.00143	CcSEcCtD
Leflunomide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000269	0.00143	CcSEcCtD
Leflunomide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000269	0.00143	CcSEcCtD
Leflunomide—Chills—Donepezil—Alzheimer's disease	0.000269	0.00143	CcSEcCtD
Leflunomide—Urinary tract disorder—Memantine—Alzheimer's disease	0.000268	0.00143	CcSEcCtD
Leflunomide—Tachycardia—Galantamine—Alzheimer's disease	0.000268	0.00142	CcSEcCtD
Leflunomide—Oedema peripheral—Memantine—Alzheimer's disease	0.000268	0.00142	CcSEcCtD
Leflunomide—Arrhythmia—Donepezil—Alzheimer's disease	0.000267	0.00142	CcSEcCtD
Leflunomide—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000267	0.00142	CcSEcCtD
Leflunomide—Connective tissue disorder—Memantine—Alzheimer's disease	0.000267	0.00142	CcSEcCtD
Leflunomide—Rhinitis—Rivastigmine—Alzheimer's disease	0.000267	0.00142	CcSEcCtD
Leflunomide—Skin disorder—Galantamine—Alzheimer's disease	0.000267	0.00142	CcSEcCtD
Leflunomide—Urethral disorder—Memantine—Alzheimer's disease	0.000266	0.00142	CcSEcCtD
Leflunomide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000266	0.00141	CcSEcCtD
Leflunomide—Hepatitis—Rivastigmine—Alzheimer's disease	0.000266	0.00141	CcSEcCtD
Leflunomide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000265	0.00141	CcSEcCtD
Leflunomide—Alopecia—Donepezil—Alzheimer's disease	0.000264	0.00141	CcSEcCtD
Leflunomide—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000264	0.0014	CcSEcCtD
Leflunomide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000263	0.0014	CcSEcCtD
Leflunomide—Mental disorder—Donepezil—Alzheimer's disease	0.000262	0.00139	CcSEcCtD
Leflunomide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000262	0.00139	CcSEcCtD
Leflunomide—Anorexia—Galantamine—Alzheimer's disease	0.000262	0.00139	CcSEcCtD
Leflunomide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000261	0.00139	CcSEcCtD
Leflunomide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000261	0.00139	CcSEcCtD
Leflunomide—Malnutrition—Donepezil—Alzheimer's disease	0.000261	0.00139	CcSEcCtD
Leflunomide—ABCG2—cerebellum—Alzheimer's disease	0.000258	0.0209	CbGeAlD
Leflunomide—Erythema multiforme—Memantine—Alzheimer's disease	0.000257	0.00137	CcSEcCtD
Leflunomide—Flatulence—Donepezil—Alzheimer's disease	0.000257	0.00137	CcSEcCtD
Leflunomide—Hypotension—Galantamine—Alzheimer's disease	0.000256	0.00136	CcSEcCtD
Leflunomide—Dysgeusia—Donepezil—Alzheimer's disease	0.000255	0.00136	CcSEcCtD
Leflunomide—Eye disorder—Memantine—Alzheimer's disease	0.000254	0.00135	CcSEcCtD
Leflunomide—Cardiac disorder—Memantine—Alzheimer's disease	0.000252	0.00134	CcSEcCtD
Leflunomide—Back pain—Donepezil—Alzheimer's disease	0.000252	0.00134	CcSEcCtD
Leflunomide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000251	0.00134	CcSEcCtD
Leflunomide—Muscle spasms—Donepezil—Alzheimer's disease	0.000251	0.00133	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00025	0.00133	CcSEcCtD
Leflunomide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000248	0.00132	CcSEcCtD
Leflunomide—Insomnia—Galantamine—Alzheimer's disease	0.000248	0.00132	CcSEcCtD
Leflunomide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000247	0.00131	CcSEcCtD
Leflunomide—Paraesthesia—Galantamine—Alzheimer's disease	0.000246	0.00131	CcSEcCtD
Leflunomide—Vision blurred—Donepezil—Alzheimer's disease	0.000246	0.00131	CcSEcCtD
Leflunomide—Immune system disorder—Memantine—Alzheimer's disease	0.000245	0.00131	CcSEcCtD
Leflunomide—Mediastinal disorder—Memantine—Alzheimer's disease	0.000245	0.0013	CcSEcCtD
Leflunomide—Chills—Memantine—Alzheimer's disease	0.000244	0.0013	CcSEcCtD
Leflunomide—Arrhythmia—Memantine—Alzheimer's disease	0.000243	0.00129	CcSEcCtD
Leflunomide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000242	0.00129	CcSEcCtD
Leflunomide—Dyspepsia—Galantamine—Alzheimer's disease	0.000242	0.00128	CcSEcCtD
Leflunomide—Anaemia—Donepezil—Alzheimer's disease	0.000241	0.00128	CcSEcCtD
Leflunomide—Alopecia—Memantine—Alzheimer's disease	0.00024	0.00128	CcSEcCtD
Leflunomide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00024	0.00127	CcSEcCtD
Leflunomide—Chills—Rivastigmine—Alzheimer's disease	0.000239	0.00127	CcSEcCtD
Leflunomide—Decreased appetite—Galantamine—Alzheimer's disease	0.000239	0.00127	CcSEcCtD
Leflunomide—Mental disorder—Memantine—Alzheimer's disease	0.000238	0.00127	CcSEcCtD
Leflunomide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000238	0.00126	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000237	0.00126	CcSEcCtD
Leflunomide—Malnutrition—Memantine—Alzheimer's disease	0.000237	0.00126	CcSEcCtD
Leflunomide—Fatigue—Galantamine—Alzheimer's disease	0.000237	0.00126	CcSEcCtD
Leflunomide—Malaise—Donepezil—Alzheimer's disease	0.000235	0.00125	CcSEcCtD
Leflunomide—Alopecia—Rivastigmine—Alzheimer's disease	0.000235	0.00125	CcSEcCtD
Leflunomide—Constipation—Galantamine—Alzheimer's disease	0.000235	0.00125	CcSEcCtD
Leflunomide—Vertigo—Donepezil—Alzheimer's disease	0.000234	0.00124	CcSEcCtD
Leflunomide—Flatulence—Memantine—Alzheimer's disease	0.000233	0.00124	CcSEcCtD
Leflunomide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000233	0.00124	CcSEcCtD
Leflunomide—Dysgeusia—Memantine—Alzheimer's disease	0.000232	0.00123	CcSEcCtD
Leflunomide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000231	0.00123	CcSEcCtD
Leflunomide—Back pain—Memantine—Alzheimer's disease	0.000229	0.00122	CcSEcCtD
Leflunomide—Flatulence—Rivastigmine—Alzheimer's disease	0.000228	0.00121	CcSEcCtD
Leflunomide—Cough—Donepezil—Alzheimer's disease	0.000227	0.00121	CcSEcCtD
Leflunomide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000227	0.00121	CcSEcCtD
Leflunomide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000226	0.0012	CcSEcCtD
Leflunomide—Hypertension—Donepezil—Alzheimer's disease	0.000225	0.0012	CcSEcCtD
Leflunomide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000224	0.00119	CcSEcCtD
Leflunomide—Back pain—Rivastigmine—Alzheimer's disease	0.000224	0.00119	CcSEcCtD
Leflunomide—Vision blurred—Memantine—Alzheimer's disease	0.000223	0.00119	CcSEcCtD
Leflunomide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000223	0.00118	CcSEcCtD
Leflunomide—Arthralgia—Donepezil—Alzheimer's disease	0.000222	0.00118	CcSEcCtD
Leflunomide—Chest pain—Donepezil—Alzheimer's disease	0.000222	0.00118	CcSEcCtD
Leflunomide—Myalgia—Donepezil—Alzheimer's disease	0.000222	0.00118	CcSEcCtD
Leflunomide—Anxiety—Donepezil—Alzheimer's disease	0.000221	0.00118	CcSEcCtD
Leflunomide—Ill-defined disorder—Memantine—Alzheimer's disease	0.00022	0.00117	CcSEcCtD
Leflunomide—Discomfort—Donepezil—Alzheimer's disease	0.000219	0.00117	CcSEcCtD
Leflunomide—Anaemia—Memantine—Alzheimer's disease	0.000219	0.00116	CcSEcCtD
Leflunomide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000218	0.00116	CcSEcCtD
Leflunomide—Dry mouth—Donepezil—Alzheimer's disease	0.000217	0.00115	CcSEcCtD
Leflunomide—Abdominal pain—Galantamine—Alzheimer's disease	0.000217	0.00115	CcSEcCtD
Leflunomide—Body temperature increased—Galantamine—Alzheimer's disease	0.000217	0.00115	CcSEcCtD
Leflunomide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000215	0.00114	CcSEcCtD
Leflunomide—Anaemia—Rivastigmine—Alzheimer's disease	0.000214	0.00114	CcSEcCtD
Leflunomide—Malaise—Memantine—Alzheimer's disease	0.000213	0.00113	CcSEcCtD
Leflunomide—Vertigo—Memantine—Alzheimer's disease	0.000213	0.00113	CcSEcCtD
Leflunomide—Leukopenia—Memantine—Alzheimer's disease	0.000212	0.00113	CcSEcCtD
Leflunomide—Infection—Donepezil—Alzheimer's disease	0.000211	0.00112	CcSEcCtD
Leflunomide—ABCG2—brain—Alzheimer's disease	0.00021	0.017	CbGeAlD
Leflunomide—Palpitations—Memantine—Alzheimer's disease	0.000209	0.00111	CcSEcCtD
Leflunomide—Malaise—Rivastigmine—Alzheimer's disease	0.000209	0.00111	CcSEcCtD
Leflunomide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000209	0.00111	CcSEcCtD
Leflunomide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000208	0.00111	CcSEcCtD
Leflunomide—Vertigo—Rivastigmine—Alzheimer's disease	0.000208	0.00111	CcSEcCtD
Leflunomide—Cough—Memantine—Alzheimer's disease	0.000206	0.0011	CcSEcCtD
Leflunomide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000206	0.00109	CcSEcCtD
Leflunomide—Palpitations—Rivastigmine—Alzheimer's disease	0.000205	0.00109	CcSEcCtD
Leflunomide—Hypertension—Memantine—Alzheimer's disease	0.000204	0.00109	CcSEcCtD
Leflunomide—Anorexia—Donepezil—Alzheimer's disease	0.000203	0.00108	CcSEcCtD
Leflunomide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000202	0.00108	CcSEcCtD
Leflunomide—Cough—Rivastigmine—Alzheimer's disease	0.000202	0.00107	CcSEcCtD
Leflunomide—Arthralgia—Memantine—Alzheimer's disease	0.000201	0.00107	CcSEcCtD
Leflunomide—Chest pain—Memantine—Alzheimer's disease	0.000201	0.00107	CcSEcCtD
Leflunomide—Myalgia—Memantine—Alzheimer's disease	0.000201	0.00107	CcSEcCtD
Leflunomide—Anxiety—Memantine—Alzheimer's disease	0.000201	0.00107	CcSEcCtD
Leflunomide—Hypertension—Rivastigmine—Alzheimer's disease	0.0002	0.00106	CcSEcCtD
Leflunomide—Discomfort—Memantine—Alzheimer's disease	0.000199	0.00106	CcSEcCtD
Leflunomide—Hypotension—Donepezil—Alzheimer's disease	0.000199	0.00106	CcSEcCtD
Leflunomide—Myalgia—Rivastigmine—Alzheimer's disease	0.000197	0.00105	CcSEcCtD
Leflunomide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000197	0.00105	CcSEcCtD
Leflunomide—Chest pain—Rivastigmine—Alzheimer's disease	0.000197	0.00105	CcSEcCtD
Leflunomide—Dry mouth—Memantine—Alzheimer's disease	0.000197	0.00105	CcSEcCtD
Leflunomide—Asthenia—Galantamine—Alzheimer's disease	0.000197	0.00105	CcSEcCtD
Leflunomide—Anxiety—Rivastigmine—Alzheimer's disease	0.000196	0.00104	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000196	0.00104	CcSEcCtD
Leflunomide—Discomfort—Rivastigmine—Alzheimer's disease	0.000195	0.00104	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000194	0.00103	CcSEcCtD
Leflunomide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000193	0.00102	CcSEcCtD
Leflunomide—Insomnia—Donepezil—Alzheimer's disease	0.000192	0.00102	CcSEcCtD
Leflunomide—Infection—Memantine—Alzheimer's disease	0.000192	0.00102	CcSEcCtD
Leflunomide—Paraesthesia—Donepezil—Alzheimer's disease	0.000191	0.00102	CcSEcCtD
Leflunomide—Dyspnoea—Donepezil—Alzheimer's disease	0.00019	0.00101	CcSEcCtD
Leflunomide—Nervous system disorder—Memantine—Alzheimer's disease	0.000189	0.00101	CcSEcCtD
Leflunomide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000189	0.00101	CcSEcCtD
Leflunomide—Tachycardia—Memantine—Alzheimer's disease	0.000188	0.001	CcSEcCtD
Leflunomide—Diarrhoea—Galantamine—Alzheimer's disease	0.000188	0.000998	CcSEcCtD
Leflunomide—Infection—Rivastigmine—Alzheimer's disease	0.000188	0.000998	CcSEcCtD
Leflunomide—Skin disorder—Memantine—Alzheimer's disease	0.000188	0.000997	CcSEcCtD
Leflunomide—Dyspepsia—Donepezil—Alzheimer's disease	0.000187	0.000996	CcSEcCtD
Leflunomide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000187	0.000993	CcSEcCtD
Leflunomide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000185	0.000985	CcSEcCtD
Leflunomide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000185	0.000984	CcSEcCtD
Leflunomide—Decreased appetite—Donepezil—Alzheimer's disease	0.000185	0.000983	CcSEcCtD
Leflunomide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000184	0.00098	CcSEcCtD
Leflunomide—Anorexia—Memantine—Alzheimer's disease	0.000184	0.000979	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000184	0.000976	CcSEcCtD
Leflunomide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000183	0.000976	CcSEcCtD
Leflunomide—Fatigue—Donepezil—Alzheimer's disease	0.000183	0.000975	CcSEcCtD
Leflunomide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000183	0.000971	CcSEcCtD
Leflunomide—Constipation—Donepezil—Alzheimer's disease	0.000182	0.000967	CcSEcCtD
Leflunomide—Pain—Donepezil—Alzheimer's disease	0.000182	0.000967	CcSEcCtD
Leflunomide—Dizziness—Galantamine—Alzheimer's disease	0.000181	0.000965	CcSEcCtD
Leflunomide—Hypotension—Memantine—Alzheimer's disease	0.00018	0.00096	CcSEcCtD
Leflunomide—Anorexia—Rivastigmine—Alzheimer's disease	0.00018	0.000958	CcSEcCtD
Leflunomide—Hypotension—Rivastigmine—Alzheimer's disease	0.000177	0.000939	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000176	0.000936	CcSEcCtD
Leflunomide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000175	0.000932	CcSEcCtD
Leflunomide—Insomnia—Memantine—Alzheimer's disease	0.000175	0.000929	CcSEcCtD
Leflunomide—Vomiting—Galantamine—Alzheimer's disease	0.000174	0.000928	CcSEcCtD
Leflunomide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000174	0.000925	CcSEcCtD
Leflunomide—Paraesthesia—Memantine—Alzheimer's disease	0.000173	0.000922	CcSEcCtD
Leflunomide—Rash—Galantamine—Alzheimer's disease	0.000173	0.00092	CcSEcCtD
Leflunomide—Dermatitis—Galantamine—Alzheimer's disease	0.000173	0.000919	CcSEcCtD
Leflunomide—Dyspnoea—Memantine—Alzheimer's disease	0.000172	0.000915	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000172	0.000915	CcSEcCtD
Leflunomide—Headache—Galantamine—Alzheimer's disease	0.000172	0.000914	CcSEcCtD
Leflunomide—Insomnia—Rivastigmine—Alzheimer's disease	0.000171	0.000909	CcSEcCtD
Leflunomide—Dyspepsia—Memantine—Alzheimer's disease	0.00017	0.000904	CcSEcCtD
Leflunomide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00017	0.000902	CcSEcCtD
Leflunomide—Urticaria—Donepezil—Alzheimer's disease	0.000169	0.000898	CcSEcCtD
Leflunomide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000168	0.000896	CcSEcCtD
Leflunomide—Abdominal pain—Donepezil—Alzheimer's disease	0.000168	0.000894	CcSEcCtD
Leflunomide—Body temperature increased—Donepezil—Alzheimer's disease	0.000168	0.000894	CcSEcCtD
Leflunomide—Decreased appetite—Memantine—Alzheimer's disease	0.000168	0.000893	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000167	0.000887	CcSEcCtD
Leflunomide—Fatigue—Memantine—Alzheimer's disease	0.000166	0.000885	CcSEcCtD
Leflunomide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000166	0.000884	CcSEcCtD
Leflunomide—Pain—Memantine—Alzheimer's disease	0.000165	0.000878	CcSEcCtD
Leflunomide—Constipation—Memantine—Alzheimer's disease	0.000165	0.000878	CcSEcCtD
Leflunomide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000164	0.000873	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000163	0.000867	CcSEcCtD
Leflunomide—Nausea—Galantamine—Alzheimer's disease	0.000163	0.000867	CcSEcCtD
Leflunomide—Fatigue—Rivastigmine—Alzheimer's disease	0.000163	0.000866	CcSEcCtD
Leflunomide—Constipation—Rivastigmine—Alzheimer's disease	0.000162	0.000859	CcSEcCtD
Leflunomide—Pain—Rivastigmine—Alzheimer's disease	0.000162	0.000859	CcSEcCtD
Leflunomide—Feeling abnormal—Memantine—Alzheimer's disease	0.000159	0.000846	CcSEcCtD
Leflunomide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000158	0.00084	CcSEcCtD
Leflunomide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000157	0.000833	CcSEcCtD
Leflunomide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000156	0.000828	CcSEcCtD
Leflunomide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000154	0.000821	CcSEcCtD
Leflunomide—Urticaria—Memantine—Alzheimer's disease	0.000153	0.000816	CcSEcCtD
Leflunomide—Abdominal pain—Memantine—Alzheimer's disease	0.000153	0.000812	CcSEcCtD
Leflunomide—Body temperature increased—Memantine—Alzheimer's disease	0.000153	0.000812	CcSEcCtD
Leflunomide—Asthenia—Donepezil—Alzheimer's disease	0.000153	0.000811	CcSEcCtD
Leflunomide—Pruritus—Donepezil—Alzheimer's disease	0.00015	0.0008	CcSEcCtD
Leflunomide—Urticaria—Rivastigmine—Alzheimer's disease	0.00015	0.000798	CcSEcCtD
Leflunomide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000149	0.000794	CcSEcCtD
Leflunomide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000149	0.000794	CcSEcCtD
Leflunomide—Diarrhoea—Donepezil—Alzheimer's disease	0.000145	0.000774	CcSEcCtD
Leflunomide—Hypersensitivity—Memantine—Alzheimer's disease	0.000142	0.000757	CcSEcCtD
Leflunomide—Dizziness—Donepezil—Alzheimer's disease	0.000141	0.000748	CcSEcCtD
Leflunomide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000139	0.00074	CcSEcCtD
Leflunomide—Asthenia—Memantine—Alzheimer's disease	0.000139	0.000737	CcSEcCtD
Leflunomide—Pruritus—Memantine—Alzheimer's disease	0.000137	0.000726	CcSEcCtD
Leflunomide—Asthenia—Rivastigmine—Alzheimer's disease	0.000136	0.000721	CcSEcCtD
Leflunomide—Vomiting—Donepezil—Alzheimer's disease	0.000135	0.000719	CcSEcCtD
Leflunomide—Rash—Donepezil—Alzheimer's disease	0.000134	0.000713	CcSEcCtD
Leflunomide—Dermatitis—Donepezil—Alzheimer's disease	0.000134	0.000712	CcSEcCtD
Leflunomide—Pruritus—Rivastigmine—Alzheimer's disease	0.000134	0.000711	CcSEcCtD
Leflunomide—Headache—Donepezil—Alzheimer's disease	0.000133	0.000708	CcSEcCtD
Leflunomide—Diarrhoea—Memantine—Alzheimer's disease	0.000132	0.000703	CcSEcCtD
Leflunomide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000129	0.000687	CcSEcCtD
Leflunomide—Dizziness—Memantine—Alzheimer's disease	0.000128	0.000679	CcSEcCtD
Leflunomide—Nausea—Donepezil—Alzheimer's disease	0.000126	0.000672	CcSEcCtD
Leflunomide—Dizziness—Rivastigmine—Alzheimer's disease	0.000125	0.000664	CcSEcCtD
Leflunomide—Vomiting—Memantine—Alzheimer's disease	0.000123	0.000653	CcSEcCtD
Leflunomide—Rash—Memantine—Alzheimer's disease	0.000122	0.000647	CcSEcCtD
Leflunomide—Dermatitis—Memantine—Alzheimer's disease	0.000122	0.000647	CcSEcCtD
Leflunomide—Headache—Memantine—Alzheimer's disease	0.000121	0.000643	CcSEcCtD
Leflunomide—Vomiting—Rivastigmine—Alzheimer's disease	0.00012	0.000639	CcSEcCtD
Leflunomide—Rash—Rivastigmine—Alzheimer's disease	0.000119	0.000633	CcSEcCtD
Leflunomide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000119	0.000633	CcSEcCtD
Leflunomide—Headache—Rivastigmine—Alzheimer's disease	0.000118	0.000629	CcSEcCtD
Leflunomide—Nausea—Memantine—Alzheimer's disease	0.000115	0.00061	CcSEcCtD
Leflunomide—Nausea—Rivastigmine—Alzheimer's disease	0.000112	0.000597	CcSEcCtD
Leflunomide—ABCG2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	7.14e-05	0.000969	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TTR—Alzheimer's disease	7.07e-05	0.00096	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—LPL—Alzheimer's disease	7.06e-05	0.000958	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—AKT1—Alzheimer's disease	6.96e-05	0.000945	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PVRL2—Alzheimer's disease	6.79e-05	0.000921	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	6.67e-05	0.000906	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	6.63e-05	0.000899	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—Alzheimer's disease	6.57e-05	0.000892	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—Alzheimer's disease	6.52e-05	0.000885	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	6.5e-05	0.000883	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	6.44e-05	0.000874	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MTHFR—Alzheimer's disease	6.36e-05	0.000863	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—Alzheimer's disease	6.2e-05	0.000842	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PYY—Alzheimer's disease	6.18e-05	0.000839	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EIF2AK2—Alzheimer's disease	6.16e-05	0.000837	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—AKT1—Alzheimer's disease	6.06e-05	0.000823	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CALM1—Alzheimer's disease	5.94e-05	0.000806	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—APOE—Alzheimer's disease	5.92e-05	0.000803	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CAV1—Alzheimer's disease	5.86e-05	0.000796	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—AKT1—Alzheimer's disease	5.72e-05	0.000777	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	5.7e-05	0.000774	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DHCR24—Alzheimer's disease	5.67e-05	0.00077	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	5.5e-05	0.000746	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDK5—Alzheimer's disease	5.36e-05	0.000728	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	5.21e-05	0.000707	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—Alzheimer's disease	5.2e-05	0.000706	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR6—Alzheimer's disease	5.16e-05	0.000701	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PPARG—Alzheimer's disease	5.16e-05	0.0007	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	5.06e-05	0.000686	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—Alzheimer's disease	5.06e-05	0.000686	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—INPP5D—Alzheimer's disease	5.02e-05	0.000682	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	4.96e-05	0.000673	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.89e-05	0.000664	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSB—Alzheimer's disease	4.84e-05	0.000656	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CA4—Alzheimer's disease	4.83e-05	0.000655	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSD—Alzheimer's disease	4.81e-05	0.000653	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—AKT1—Alzheimer's disease	4.78e-05	0.000649	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	4.76e-05	0.000646	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PPP3CA—Alzheimer's disease	4.74e-05	0.000643	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PSENEN—Alzheimer's disease	4.69e-05	0.000636	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.65e-05	0.000632	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APH1A—Alzheimer's disease	4.62e-05	0.000627	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GAB2—Alzheimer's disease	4.54e-05	0.000617	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GAPDHS—Alzheimer's disease	4.54e-05	0.000616	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GSK3A—Alzheimer's disease	4.5e-05	0.000611	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NCSTN—Alzheimer's disease	4.5e-05	0.000611	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.48e-05	0.000609	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.45e-05	0.000604	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NOS3—Alzheimer's disease	4.43e-05	0.000602	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—APP—Alzheimer's disease	4.43e-05	0.000601	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	4.43e-05	0.000601	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LRP1—Alzheimer's disease	4.39e-05	0.000596	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—AKT1—Alzheimer's disease	4.35e-05	0.000591	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	4.32e-05	0.000587	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ATP5A1—Alzheimer's disease	4.3e-05	0.000584	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.29e-05	0.000583	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GFAP—Alzheimer's disease	4.29e-05	0.000582	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GAL—Alzheimer's disease	4.29e-05	0.000582	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	4.24e-05	0.000575	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.18e-05	0.000567	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	4.15e-05	0.000563	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLD3—Alzheimer's disease	4.1e-05	0.000557	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTGS2—Alzheimer's disease	4.06e-05	0.00055	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.98e-05	0.00054	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HSD17B10—Alzheimer's disease	3.93e-05	0.000534	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.81e-05	0.000518	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP46A1—Alzheimer's disease	3.79e-05	0.000514	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—A2M—Alzheimer's disease	3.78e-05	0.000513	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	3.75e-05	0.000509	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.67e-05	0.000498	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PSEN2—Alzheimer's disease	3.66e-05	0.000497	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ND1—Alzheimer's disease	3.66e-05	0.000496	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—S100B—Alzheimer's disease	3.6e-05	0.000489	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	3.44e-05	0.000467	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPY—Alzheimer's disease	3.37e-05	0.000457	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IAPP—Alzheimer's disease	3.35e-05	0.000454	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1A—Alzheimer's disease	3.26e-05	0.000442	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CRH—Alzheimer's disease	3.25e-05	0.000441	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	3.21e-05	0.000436	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	3.21e-05	0.000436	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MEF2C—Alzheimer's disease	3.15e-05	0.000427	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AGER—Alzheimer's disease	3.12e-05	0.000424	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRKCG—Alzheimer's disease	3.09e-05	0.000419	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NPS—Alzheimer's disease	3.08e-05	0.000418	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PPP3CA—Alzheimer's disease	3.06e-05	0.000416	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	3.04e-05	0.000413	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GAB2—Alzheimer's disease	2.94e-05	0.000399	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NTRK2—Alzheimer's disease	2.94e-05	0.000399	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SST—Alzheimer's disease	2.94e-05	0.000399	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GSK3A—Alzheimer's disease	2.91e-05	0.000395	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.87e-05	0.000389	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APP—Alzheimer's disease	2.86e-05	0.000389	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PLCB1—Alzheimer's disease	2.7e-05	0.000367	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CALM1—Alzheimer's disease	2.67e-05	0.000363	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.67e-05	0.000363	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.67e-05	0.000362	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGFR—Alzheimer's disease	2.52e-05	0.000342	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADAM10—Alzheimer's disease	2.46e-05	0.000334	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.45e-05	0.000332	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.44e-05	0.000331	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.38e-05	0.000323	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CHAT—Alzheimer's disease	2.36e-05	0.00032	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TPI1—Alzheimer's disease	2.36e-05	0.00032	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—S100B—Alzheimer's disease	2.33e-05	0.000316	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—GSK3B—Alzheimer's disease	2.31e-05	0.000313	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.29e-05	0.000311	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CREB1—Alzheimer's disease	2.29e-05	0.000311	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.28e-05	0.00031	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOB—Alzheimer's disease	2.26e-05	0.000307	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF2—Alzheimer's disease	2.22e-05	0.000301	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GAPDH—Alzheimer's disease	2.17e-05	0.000295	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.17e-05	0.000295	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1R—Alzheimer's disease	2.14e-05	0.000291	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—A2M—Alzheimer's disease	2.1e-05	0.000285	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CA4—Alzheimer's disease	2.08e-05	0.000283	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.07e-05	0.000281	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.07e-05	0.000281	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LPL—Alzheimer's disease	2.05e-05	0.000279	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.05e-05	0.000278	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AKT1—Alzheimer's disease	2.04e-05	0.000277	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MEF2C—Alzheimer's disease	2.04e-05	0.000276	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.04e-05	0.000276	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRKCG—Alzheimer's disease	2e-05	0.000271	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.99e-05	0.00027	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.96e-05	0.000266	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGF—Alzheimer's disease	1.95e-05	0.000264	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.94e-05	0.000264	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—BCL2—Alzheimer's disease	1.92e-05	0.000261	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.91e-05	0.00026	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—Alzheimer's disease	1.89e-05	0.000257	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.86e-05	0.000252	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.85e-05	0.000251	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.85e-05	0.000251	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ACHE—Alzheimer's disease	1.83e-05	0.000248	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INPP5D—Alzheimer's disease	1.81e-05	0.000245	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.81e-05	0.000245	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.77e-05	0.00024	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.77e-05	0.00024	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.75e-05	0.000238	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CALM1—Alzheimer's disease	1.73e-05	0.000235	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—LEP—Alzheimer's disease	1.72e-05	0.000234	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOE—Alzheimer's disease	1.72e-05	0.000234	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ENO1—Alzheimer's disease	1.71e-05	0.000232	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS1—Alzheimer's disease	1.71e-05	0.000232	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CAV1—Alzheimer's disease	1.71e-05	0.000232	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—Alzheimer's disease	1.7e-05	0.00023	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.7e-05	0.00023	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2D6—Alzheimer's disease	1.68e-05	0.000228	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.66e-05	0.000225	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.65e-05	0.000224	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ESR1—Alzheimer's disease	1.64e-05	0.000223	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.63e-05	0.000222	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—F2—Alzheimer's disease	1.62e-05	0.00022	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—BCHE—Alzheimer's disease	1.59e-05	0.000216	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.59e-05	0.000216	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.58e-05	0.000214	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK8—Alzheimer's disease	1.56e-05	0.000211	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.54e-05	0.000209	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLCB1—Alzheimer's disease	1.5e-05	0.000204	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GSK3B—Alzheimer's disease	1.49e-05	0.000202	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CREB1—Alzheimer's disease	1.48e-05	0.000201	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—Alzheimer's disease	1.47e-05	0.0002	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCA1—Alzheimer's disease	1.46e-05	0.000198	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL2—Alzheimer's disease	1.45e-05	0.000196	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—Alzheimer's disease	1.42e-05	0.000193	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.42e-05	0.000193	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.41e-05	0.000192	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.3e-05	0.000176	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-05	0.000175	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	1.25e-05	0.00017	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—Alzheimer's disease	1.25e-05	0.00017	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.22e-05	0.000165	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.19e-05	0.000162	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.19e-05	0.000162	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—LPL—Alzheimer's disease	1.14e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.14e-05	0.000155	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.11e-05	0.00015	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	0.000149	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CASP3—Alzheimer's disease	1.1e-05	0.000149	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.09e-05	0.000147	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.08e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.06e-05	0.000144	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	0.00014	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.02e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.02e-05	0.000138	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.01e-05	0.000137	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—Alzheimer's disease	9.94e-06	0.000135	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOB—Alzheimer's disease	9.75e-06	0.000132	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CALM1—Alzheimer's disease	9.61e-06	0.00013	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—Alzheimer's disease	9.58e-06	0.00013	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAV1—Alzheimer's disease	9.49e-06	0.000129	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.46e-06	0.000128	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	9.39e-06	0.000127	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VEGFA—Alzheimer's disease	9.3e-06	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.28e-06	0.000126	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.23e-06	0.000125	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.19e-06	0.000125	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—AKT1—Alzheimer's disease	9.17e-06	0.000125	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.12e-06	0.000124	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—A2M—Alzheimer's disease	9.07e-06	0.000123	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.65e-06	0.000117	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.65e-06	0.000117	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—Alzheimer's disease	8.53e-06	0.000116	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.48e-06	0.000115	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PPARG—Alzheimer's disease	8.34e-06	0.000113	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—Alzheimer's disease	8.18e-06	0.000111	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.08e-06	0.00011	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.04e-06	0.000109	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.89e-06	0.000107	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.8e-06	0.000106	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.59e-06	0.000103	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.44e-06	0.000101	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ENO1—Alzheimer's disease	7.39e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	7.39e-06	0.0001	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.35e-06	9.98e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	7.25e-06	9.84e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—Alzheimer's disease	7.17e-06	9.74e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—Alzheimer's disease	7.02e-06	9.53e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.87e-06	9.32e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTGS2—Alzheimer's disease	6.56e-06	8.91e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.48e-06	8.8e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—Alzheimer's disease	6.43e-06	8.73e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.36e-06	8.63e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.34e-06	8.6e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.31e-06	8.56e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	6.28e-06	8.53e-05	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—AKT1—Alzheimer's disease	5.93e-06	8.05e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.77e-06	7.83e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.42e-06	7.35e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.39e-06	7.32e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.2e-06	7.05e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.93e-06	6.69e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.85e-06	6.59e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.84e-06	6.56e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.79e-06	6.5e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.44e-06	6.03e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.21e-06	5.72e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.15e-06	5.63e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—Alzheimer's disease	4.13e-06	5.61e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—Alzheimer's disease	4.13e-06	5.61e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.09e-06	5.56e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.62e-06	4.92e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.6e-06	4.89e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—Alzheimer's disease	3.53e-06	4.79e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	4.5e-05	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKT1—Alzheimer's disease	3.3e-06	4.48e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.1e-06	4.2e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.83e-06	3.84e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.67e-06	2.26e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.42e-06	1.93e-05	CbGpPWpGaD
